ESGCT

October 4, 2023

ESGCT

ESGCT: European Society of Gene & Cell Therapy

24-27 october 2023 | Brussels

https://anemocyte.com/wp-content/uploads/2023/10/AMC_2023-ESG.jpg 1200 900 Anemocyte Anemocyte https://anemocyte.com/wp-content/uploads/2023/10/AMC_2023-ESG.jpg October 4, 2023 May 27, 2024

Anemocyte S.r.l. Single Shareholder Private Limited-Liability Company
Via R. Lepetit, 34 21040 Gerenzano (VA) Italy | Ph: +39 02 99372311 – Fax: +39 02 99372313 | VAT number: 12914940155 | Share capital € 530.000,00 fully paid | R.E.A. 276961

Privacy & cookie Policy

ESGCT

ESGCT

ESGCT: European Society of Gene & Cell Therapy

24-27 october 2023 | Brussels

Anemocyte Pioneers Safer Horizons in Gene Therapy with Non-Viral Genetic Modification Techniques

The Perfect Recipe: Driving Sustainability, Flexibility, Quality, and Innovation in Cell and Gene Therapy

Our DNA: A Culture of Teamwork, Safety, and Strategic Growth